U.S. Mortgage Finance Stock News

Wellgistics Health (WGRX) just grabbed the spotlight after revealing plans to collaborate with DataVault AI on blockchain-enabled smart contract integration for its prescription drug distribution network. This partnership is intended to transform drug tracking and improve overall patient safety. See our latest analysis for Wellgistics Health. Momentum is unmistakably back for Wellgistics Health, with the blockchain partnership headline sending its share price soaring 185% in the past day and...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights The projected fair value for NOV is US$21.13 based on 2 Stage Free Cash Flow to Equity Current share price...

As the U.S. stock market reaches record highs, buoyed by a tame inflation reading and expectations of an interest rate cut by the Federal Reserve, investors are increasingly turning their attention to small-cap stocks as potential opportunities for growth. In this vibrant landscape, identifying promising stocks involves looking for companies that demonstrate resilience and adaptability in navigating economic shifts and leveraging emerging trends.

The Morning Bull - US Market Morning Update Monday, Oct, 27 2025 US stock futures are pointing higher ahead of the open, with investors cheering early momentum in trade talks between the US and China. Hopes that a deal is within reach have dialed back trade tensions and added optimism to markets, even as questions linger about inflation and how much relief lower rates might provide. This has prompted investors to weigh whether upbeat economic activity can overcome ongoing concerns about the...

Immix Biopharma, Inc. ( NASDAQ:IMMX ) insiders who purchased shares in the last 12 months were richly rewarded last...

In recent days, Churchill Capital Corp X saw a surge in bullish options activity, as 8,562 call contracts traded, double the expected volume, and implied volatility spiked. This unusually low Put/Call ratio of 0.14 and concentrated action in November call options highlight significant optimism among options traders regarding the company's outlook. With the spotlight on heightened call trading, we’ll explore how shifting market sentiment may influence Churchill Capital Corp X’s investment...

Obook Holdings (OWLS) has shown some movement lately, and investors may be taking a closer look at the company based on its recent stock performance. Shares closed at $12.60, which is an increase of nearly 18% in the last trading session. See our latest analysis for Obook Holdings. Obook Holdings’ one-day share price return of 17.98% stands out after a tough year. However, this rebound comes on the heels of a steep 77.32% decline in the year-to-date share price return, which shows momentum...

Thermon Group Holdings' (NYSE:THR) stock is up by a considerable 6.8% over the past week. We wonder if and what role...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

We feel now is a pretty good time to analyse LifeStance Health Group, Inc.'s ( NASDAQ:LFST ) business as it appears the...

On October 22, 2025, DataVault AI, Inc. and Wellgistics Health, Inc. announced a non-binding letter of intent to integrate manufacturer-to-patient blockchain-enabled smart contracts into Wellgistics' prescription drug infrastructure, aiming to fully digitize tracking from script to fulfillment across more than 6,500 pharmacies nationwide. A unique aspect of this partnership is its focus on leveraging AI agents and digital routing tools to optimize prescription drug services while enhancing...

Ventyx Biosciences recently announced positive topline results from its Phase 2 clinical trial of VTX3232, showing significant reductions in key inflammatory biomarkers such as hsCRP and IL-6 in patients with obesity and cardiovascular risk factors. An interesting insight from the study is that VTX3232 achieved a robust safety and tolerability profile, both as a standalone therapy and in combination with semaglutide, highlighting its potential as a new oral anti-inflammatory option in...

Bullish momentum is building around Churchill Capital Corp X (CCCX) as options traders pile into call contracts. Volumes have doubled the norm and implied volatility is spiking. The extremely low Put/Call Ratio suggests that optimism is widespread. See our latest analysis for Churchill Capital Corp X. After a quiet start to the year, Churchill Capital Corp X’s share price has climbed significantly in recent weeks, notching a 51.8% gain over the past month and doubling since the beginning of...

MoneyGram Haas F1 Team recently announced a new partnership with CSG Systems International, debuting their collaboration at the 2025 Formula 1 United States Grand Prix in Austin, Texas, to emphasize their shared commitment to innovation and performance. This partnership leverages the global exposure and fast-paced environment of Formula 1 racing to highlight CSG's expertise in empowering brands to engage customers and manage complexity. We'll now examine how CSG's new Formula 1 alliance...

Arcturus Therapeutics Holdings (ARCT) drew intense investor attention after it released interim results from a Phase 2 trial for its cystic fibrosis treatment, ARCT-032. The report showed no substantial lung function improvement, which triggered sharp share declines and analyst downgrades. See our latest analysis for Arcturus Therapeutics Holdings. It has been a turbulent year for Arcturus Therapeutics. Shares have dropped sharply after underwhelming trial news and legal scrutiny, leading to...

Coya Therapeutics has completed a $20 million follow-on equity offering. The company aims to strengthen its cash position and accelerate progress in the Phase 2 trial of COYA 302, its experimental ALS therapy. Investors are watching these milestones closely, as the FDA's recent acceptance of Coya's drug application and a triggered milestone payment bring new attention to the company’s clinical and financial strategy. See our latest analysis for Coya Therapeutics. After announcing the equity...

ETHZilla is drawing attention after unveiling a $15 million strategic partnership with Satschel, Inc., parent of Liquidity.io. This collaboration gives ETHZilla a 15% equity stake as well as exclusive rights within regulated digital asset markets. See our latest analysis for ETHZilla. Momentum has picked up again for ETHZilla after the Satschel investment, with the share price jumping 17.38% in just the last day and 7.32% over the past week, though recent news-fueled rallies come against the...

Earlier this week, Luminar Technologies announced that its lidar technology is now integrated into Volvo’s EX90 and is being included on platforms from Mercedes-Benz, NVIDIA, and Mobileye, while it also provided updates on its next-generation “Halo” chipset and production plans for late 2025 and early 2026. An interesting takeaway is that despite these prominent partnerships and advancements, the company revised its full-year 2025 guidance downward due to slower automotive ramp-up, winding...

Eightco Holdings (ORBS) is in the spotlight again after its move to adopt Worldcoin as a primary reserve asset and bring Dan Ives on board as chairman. This shake-up has sparked renewed interest and rapid price swings. See our latest analysis for Eightco Holdings. ORBS has seen one of the most dramatic runs among speculative stocks this year, with the 1-year total shareholder return at nearly 231%. Yet, this surge comes after years of heavy losses, a delisting, and repeated pivoting between...

Flux Power Holdings (FLUX) has regained compliance with Nasdaq’s listing rules after facing a potential delisting. This development is likely to boost investor confidence and renew interest in the company’s prospects. See our latest analysis for Flux Power Holdings. Regaining Nasdaq compliance comes after a dramatic surge in Flux Power Holdings’ share price, with a 30-day share price return of 85.5% and a striking year-to-date gain of 252.9%. That momentum has reignited interest, especially...